Because of its small size, a focus in breast magnetic resonance imaging (MRI) must be evaluated on the basis of characteristics other than morphologic features. Patient-related factors including patient age, in conjunction with lesion-related factors, could be useful for decision-making.
Purpose
To assess the probability of malignant foci based on both lesion- and patient-related factors, and to propose a relevant decision-making method.
Material and Methods
Foci in our breast MRI database dating from April 2006 to June 2013 were retrospectively identified and analyzed. A Fisher’s exact test or a Mann–Whitney U test were performed for univariate analyses, and factors that showed a significant association with outcome in the univariate analyses were subjected to multivariate analysis using a logistic regression model. A decision tree was then drawn using the significant predictors confirmed by multivariate analysis.
Results
In total, 184 foci (168 benign, 16 malignant) in 184 patients were analyzed in our study. The presence of a washout pattern and older age were found to be significant predictors of malignancy (P < 0.0001; odds ratio [OR], 17.8; P = 0.021; OR, 1.1, respectively). The main decisive node on the decision tree was the presence of a washout pattern, followed by whether the patient’s age was >63 years.
Conclusion
An enhancing focus showing a washout pattern, especially in older patients, may warrant immediate biopsy rather than short-interval follow-up.
American College of Radiology (ACR). ACR BI-RADS Atlas: Breast imaging reporting and data system : mammography, ultrasound, magnetic resonance imaging, follow-up and outcome monitoring, data dictionary. 5th ed. Reston, VA: American College of Radiology, 2013.
2.
HaRSungJLeeC. Characteristics and outcome of enhancing foci followed on breast MRI with management implications. Clin Radiol2014; 69: 715–720.
3.
EbyPRDeMartiniWBGutierrezRL. Characteristics of probably benign breast MRI lesions. Am J Roentgenol2009; 193: 861–867.
4.
AbeHSchmidtRAShahRN. MR-directed (“Second-Look”) ultrasound examination for breast lesions detected initially on MRI: MR and sonographic findings. Am J Roentgenol2010; 194: 370–377.
5.
JansenSAShimauchiAZakL. The diverse pathology and kinetics of mass, nonmass, and focus enhancement on MR imaging of the breast. J Magn Reson Imaging2011; 33: 1382–1389.
6.
DietzelMBaltzerPAVagT. Differential diagnosis of breast lesions 5 mm or less: is there a role for magnetic resonance imaging?J Comput Assist Tomogr2010; 34: 456–464.
7.
MilletICurros-DoyonFMolinariN. Invasive breast carcinoma: influence of prognosis and patient-related factors on kinetic MR imaging characteristics. Radiology2014; 270: 57–66.
8.
KingVGuYKaplanJB. Impact of menopausal status on background parenchymal enhancement and fibroglandular tissue on breast MRI. Eur Radiol2012; 22: 2641–2647.
9.
GutierrezRLDemartiniWBEbyP. Clinical indication and patient age predict likelihood of malignancy in suspicious breast MRI lesions. Acad Radiol2009; 16: 1281–1285.
10.
KurosakiMMatsunagaKHirayamaI. A predictive model of response to peginterferon ribavirin in chronic hepatitis C using classification and regression tree analysis. Hepatol Res2010; 40: 251–260.
11.
ZayedNAwadABEl-AkelW. The assessment of data mining for the prediction of therapeutic outcome in 3719 Egyptian patients with chronic hepatitis C. Clin Res Hepatol Gastroenterol2013; 37: 254–261.
12.
AleskandaranyMASoriaDGreenAR. Markers of progression in early-stage invasive breast cancer: a predictive immunohistochemical panel algorithm for distant recurrence risk stratification. Breast Cancer Res Treat2015; 151: 325–333.
13.
YadavKSariogluEChoiHA. Automated outcome classification of computed tomography imaging reports for pediatric traumatic brain injury. Acad Emerg Med2016; 23: 171–178.
14.
HabibiSAhmadiMAlizadehS. Type 2 diabetes mellitus screening and risk factors using decision tree: results of data mining. Glob J Health Sci2015; 7: 304–310.
15.
FerreiraDOliveiraAFreitasA. Applying data mining techniques to improve diagnosis in neonatal jaundice. BMC Med Inform Decis Mak2012; 12: 143–143.
16.
DolceGQuintieriMSerraS. Clinical signs and early prognosis in vegetative state: a decisional tree, data-mining study. Brain Inj2008; 22: 617–623.
17.
KuhlCKSchildHHMorakkabatiN. Dynamic bilateral contrast-enhanced MR imaging of the breast: trade-off between spatial and temporal resolution. Radiology2005; 236: 789–800.
18.
KuhlCKMielcareckPKlaschikS. Dynamic breast MR imaging: are signal intensity time course data useful for differential diagnosis of enhancing lesions?Radiology1999; 211: 101–110.
19.
KuhlCKKlaschikSMielcarekP. Do T2-weighted pulse sequences help with the differential diagnosis of enhancing lesions in dynamic breast MRI?J Magn Reson Imaging1999; 9: 187–196.
20.
MalichAFischerDRWurdingerS. Potential MRI interpretation model: differentiation of benign from malignant breast masses. Am J Roentgenol2005; 185: 964–970.
21.
KingVKaplanJPikeMC. Impact of tamoxifen on amount of fibroglandular tissue, background parenchymal enhancement, and cysts on breast magnetic resonance imaging. Breast J2012; 18: 527–534.
22.
SchradingSSchildHKuhrM. Effects of tamoxifen and aromatase inhibitors on breast tissue enhancement in dynamic contrast-enhanced breast MR imaging: a longitudinal intraindividual cohort study. Radiology2014; 271: 45–55.
23.
SchradingSKuhlCK. Breast cancer: influence of taxanes on response assessment with dynamic contrast-enhanced MR imaging. Radiology2015; 277: 687–696.
24.
GrimmLJAndersonALBakerJA. Frequency of malignancy and imaging characteristics of probably benign lesions seen at breast MRI. Am J Roentgenol2015; 205: 442–447.
25.
HegenscheidKSchmidtCOSeipelR. Contrast enhancement kinetics of normal breast parenchyma in dynamic MR mammography: effects of menopausal status, oral contraceptives, and postmenopausal hormone therapy. Eur Radiol2012; 22: 2633–2640.
26.
HegenscheidKSchmidtCOSeipelR. Normal breast parenchyma: contrast enhancement kinetics at dynamic MR mammography–influence of anthropometric measures and menopausal status. Radiology2013; 266: 72–80.
27.
O’FlynnEAMorganVAGilesSL. Diffusion weighted imaging of the normal breast: reproducibility of apparent diffusion coefficient measurements and variation with menstrual cycle and menopausal status. Eur Radiol2012; 22: 1512–1518.
28.
ShinSKoESKimRB. Effect of menstrual cycle and menopausal status on apparent diffusion coefficient values and detectability of invasive ductal carcinoma on diffusion-weighted MRI. Breast Cancer Res Treat2015; 149: 751–759.
29.
Tilanus-LinthorstMMObdeijnIMBartelsKC. First experiences in screening women at high risk for breast cancer with MR imaging. Breast Cancer Res Treat2000; 63: 53–60.
30.
SardanelliFPodoF. Breast MR imaging in women at high-risk of breast cancer. Is something changing in early breast cancer detection?Eur Radiol2007; 17: 873–887.
31.
KuhlCWeigelSSchradingS. Prospective multicenter cohort study to refine management recommendations for women at elevated familial risk of breast cancer: the EVA trial. J Clin Oncol2010; 28: 1450–1457.
